Delivery Order SPE2DB22D2206-SPE2DB25FJD02
- Not listed
- The Defense Logistics Agency awarded a $2,778.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials. This contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, involves no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials with a ceiling value of $5,556.00. This is a firm fixed-price delivery order issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award was not set aside and represents a competitive award to the prime contractor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $76,960 delivery order to Amerisourcebergen Drug Corporation for buprenorphine hydrochloride injection in 0.3 mg/mL vials. The firm fixed price order is being fulfilled under an existing Prime Vendor Program contract vehicle and calls for delivery to a facility in Conshohocken, Pennsylvania by July 7, 2023. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen will leverage its extensive distribution network to provide this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency Troop Support Medical awarded a $3,611 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.3 mg/ml buprenorphine vials. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 22nd to 23rd, 2023 is under an existing indefinite delivery/indefinite quantity contract vehicle held by Amerisourcebergen with the agency. As a leading pharmaceutical distributor, Amerisourcebergen will...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 2 mg buprenorphine tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 30-count bottles of the tablets to a location in Conshohocken, Pennsylvania by August 21, 2023 to support Defense Logistics Agency pharmaceutical needs. No set aside designation or subcontractors were identified. This delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 buprenorphine 2 mg tablets. The firm fixed price order is to be performed in Conshohocken, Pennsylvania from July 13-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the opioid addiction treatment medication to support the Agency's health services for service members and their families. No set aside designation or...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the provision of 2 mg buprenorphine tablets. The firm fixed price order is for 30 tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by July 21, 2023. As the DLA supports Department of Defense procurement and supply chain management, this small order for opioid addiction treatment medication was likely placed to support medical...
- The Defense Logistics Agency Troop Support Medical awarded a $549 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg buprenorphine tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. This delivery order was issued against an existing DLA medical supply vehicle and will provide the agency with a one-day supply of an opioid addiction...
- The Defense Logistics Agency awarded a $138,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.3 mg/ml buprenorphine vials. The single day contract has a period of performance from August 1-2, 2023, with all work to be conducted by the prime contractor at its Conshohocken, Pennsylvania facility. As the DLA supports military treatment programs, this award is likely associated with its pharmaceutical prime vendor indefinite-delivery/indefinite-quantity contract to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD02Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Buprenorphine, an opioid medication used for pain management and opioid use disorder treatment, represents part of the company's extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, and medical supplies distributed through the DLA Medical Supply Chain. AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical vendor for federal medical procurement, with delivery orders demonstrating consistent capability to fulfill diverse healthcare commodity requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/29/25 |